A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol

Author： Devroey P.   Boostanfar R.   Koper N.P.   Mannaerts B.M.J.L.   IJzerman-Boon P.C.   Fauser B.C.J.M.  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.24, Iss.12, 2009-12, pp. : 3063-3072

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized, double‐blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction

By Out Henk J.  

Human Reproduction, Vol. 19, Iss. 1, 2004-01 ,pp. : 90-95

Oxford University Press

Access to resources Recommend Favorite

Poor prognosis for ovarian response to stimulation: results of a randomised trial comparing the flare-up GnRH agonist protocol vs. the antagonist protocol

By Devesa Marta   Martínez Francisca   Coroleu Buenaventura   Tur Rosa   González Clara   Rodríguez Ignacio   Barri Pedro N.  

Gynecological Endocrinology, Vol. 26, Iss. 7, 2010-07 ,pp. : 509-515

Informa Healthcare

Access to resources Recommend Favorite

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

By European Middle East Orgalutran® Study Group* The  

Human Reproduction, Vol. 16, Iss. 4, 2001-04 ,pp. : 644-651

Oxford University Press

Access to resources Recommend Favorite

Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment

By Devroey Paul   Aboulghar Mohamed   Garcia-Velasco Juan   Griesinger Georg   Humaidan Peter   Kolibianakis Efstratios   Ledger William   Toms Candido   Fauser Bart C.J.M.  

Human Reproduction, Vol. 24, Iss. 4, 2009-04 ,pp. : 764-774

Oxford University Press

Access to resources Recommend Favorite

Protection of ovarian function and fertility using a combination of gonadotropin-releasing hormone ((GnRH)) agonist and GnRH antagonist during cancer treatment in young females

By Potolog-Nahari Claris   Fishman Ami   Cohen Ilan  

Gynecological Endocrinology, Vol. 23, Iss. 5, 2007-11 ,pp. : 290-294

Informa Healthcare

Access to resources Recommend Favorite